High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates. (2022)
Attributed to:
Using host-responses and pathogen genomics to improve diagnostics for tuberculosis in the Philippines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/22221751.2022.2099304
PubMed Identifier: 35792049
Publication URI: http://europepmc.org/abstract/MED/35792049
Type: Journal Article/Review
Volume: 11
Parent Publication: Emerging microbes & infections
Issue: 1
ISSN: 2222-1751